Covered recipient · General Payments record
ARYANNA MUSME DE ARAUJO E SOUSA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2024
$392.13
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $392.13 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $243.17 | 14 |
| Inari Medical, Inc. | $87.57 | 1 |
| Alexion Pharmaceuticals, Inc. | $33.97 | 1 |
| Phathom Pharmaceuticals, Inc. | $27.42 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $392.13 | 17 |
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.23 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612818 | CMS |
| ABBVIE INC. | $12.17 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612820 | CMS |
| ABBVIE INC. | $15.76 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612822 | CMS |
| ABBVIE INC. | $5.37 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612824 | CMS |
| ABBVIE INC. | $22.00 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612826 | CMS |
| ABBVIE INC. | $16.99 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612828 | CMS |
| ABBVIE INC. | $20.64 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612830 | CMS |
| ABBVIE INC. | $20.57 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612832 | CMS |
| ABBVIE INC. | $20.55 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612834 | CMS |
| ABBVIE INC. | $19.70 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612836 | CMS |
| ABBVIE INC. | $19.70 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612838 | CMS |
| ABBVIE INC. | $23.24 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612840 | CMS |
| ABBVIE INC. | $5.98 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612842 | CMS |
| ABBVIE INC. | $17.27 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103612844 | CMS |
| Alexion Pharmaceuticals, Inc. | $33.97 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094045414 | CMS |
| Inari Medical, Inc. | $87.57 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140076391 | CMS |
| Phathom Pharmaceuticals, Inc. | $27.42 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151054335 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.